Glufosfamide: Phase II data

In an open-label Phase II trial in 15 patients, 1-hour infusions of 5,000 µg/m² of glufosfamide as first-line therapy every 3 weeks gave 2 partial responses and 6 cases of stable disease. In the 17-mo...